Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model.

Mishra J, Dey A, Singh N, Somvanshi R, Singh S.

Indian J Med Res. 2013 Apr;137(4):767-76.

2.

Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.

Khan MA, Owais M.

J Antimicrob Chemother. 2006 Jul;58(1):125-32. Epub 2006 May 18.

PMID:
16709592
3.

Lipid formulations of amphotericin b in the treatment of experimental visceral leishmaniasis due to Leishmania infantum.

Gangneux JP, Sulahian A, Garin YJ, Derouin F.

Trans R Soc Trop Med Hyg. 1996 Sep-Oct;90(5):574-7.

PMID:
8944278
4.

Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model.

Paul M, Durand R, Fessi H, Rivollet D, Houin R, Astier A, Deniau M.

Antimicrob Agents Chemother. 1997 Aug;41(8):1731-4.

5.

Liposomal amphotericin B in the treatment of visceral leishmaniasis.

Croft SL, Davidson RN, Thornton EA.

J Antimicrob Chemother. 1991 Oct;28 Suppl B:111-8.

PMID:
1778888
6.

Antileishmanial activity of nano-amphotericin B deoxycholate.

Manandhar KD, Yadav TP, Prajapati VK, Kumar S, Rai M, Dube A, Srivastava ON, Sundar S.

J Antimicrob Chemother. 2008 Aug;62(2):376-80. doi: 10.1093/jac/dkn189. Epub 2008 May 2.

PMID:
18453526
7.

Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.

Gangneux JP, Sulahian A, Garin YJ, Farinotti R, Derouin F.

Antimicrob Agents Chemother. 1996 May;40(5):1214-8.

8.

Liposomal amphotericin B in drug-resistant visceral leishmaniasis.

Davidson RN, Croft SL, Scott A, Maini M, Moody AH, Bryceson AD.

Lancet. 1991 May 4;337(8749):1061-2.

PMID:
1673494
9.
10.

Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.

Roychoudhury J, Sinha R, Ali N.

PLoS One. 2011 Mar 10;6(3):e17376. doi: 10.1371/journal.pone.0017376.

11.
12.

[Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009].

Rosenthal E, Delaunay P, Jeandel PY, Haas H, Pomares-Estran C, Marty P.

Med Mal Infect. 2009 Oct;39(10):741-4. doi: 10.1016/j.medmal.2009.05.001. Epub 2009 Sep 23. Review. French.

PMID:
19783391
14.
15.

Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis.

Al-Abdely HM, Graybill JR, Bocanegra R, Najvar L, Montalbo E, Regen SL, Melby PC.

Antimicrob Agents Chemother. 1998 Oct;42(10):2542-8.

16.

Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.

Wasan KM, Wasan EK, Gershkovich P, Zhu X, Tidwell RR, Werbovetz KA, Clement JG, Thornton SJ.

J Infect Dis. 2009 Aug 1;200(3):357-60. doi: 10.1086/600105.

PMID:
19545212
17.

Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.

Khan MA, Nasti TH, Owais M.

J Antimicrob Chemother. 2005 Oct;56(4):726-31. Epub 2005 Aug 26.

PMID:
16126780
18.

Single-dose liposomal amphotericin B for visceral leishmaniasis in India.

Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW.

N Engl J Med. 2010 Feb 11;362(6):504-12. doi: 10.1056/NEJMoa0903627.

19.

Liposomal amphotericin B for the treatment of visceral leishmaniasis.

Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J.

Clin Infect Dis. 2006 Oct 1;43(7):917-24. Epub 2006 Aug 28.

PMID:
16941377
20.

Development and performance evaluation of amphotericin B transfersomes against resistant and sensitive clinical isolates of visceral leishmaniasis.

Singodia D, Gupta GK, Verma A, Singh V, Shukla P, Misra P, Sundar S, Dube A, Mishra PR.

J Biomed Nanotechnol. 2010 Jun;6(3):293-302.

PMID:
21179947

Supplemental Content

Support Center